头条新闻！数魅 S-B2R RGB 摄影补光灯亮相：强劲续航 多样功能，助力摄影创作

数魅 S-B2R RGB 摄影补光灯亮相：强劲续航 多样功能，助力摄影创作

2024年6月17日 - 数魅科技今日发布 S-B2R RGB 摄影补光灯，为摄影爱好者和专业人士带来一款功能强大、续航持久、操作简便的补光神器。S-B2R 拥有众多亮点，可满足多种摄影场景需求，助力用户轻松创作出精彩影像。

强劲续航，持久助力

S-B2R 内置 4000mAh 大容量电池，满功率运行续航约 90 分钟，可满足长时间拍摄需求。同时，S-B2R 还支持 USB-A 和 Type-C 双向快充，可在 2 小时内充满电，让您无后顾之忧地进行创作。

多种光效，创意无限

S-B2R 拥有 135 颗 LED 灯珠，支持 2800K 至 6800K 的广域色温调节，显色指数 (CRI) 超过 80Ra，可提供自然逼真的光线效果。此外，S-B2R 还支持无极调光和 9 种创意场景光效模式，包括雷电、坏灯泡等，可满足用户在不同环境下的拍摄需求。

便携实用，操作简便

S-B2R 采用轻巧便携的铝合金机身，重量仅为 240g，方便随身携带。同时，S-B2R 配备两个 1/4 螺纹接口，可横向或竖向安装，兼容相机、三脚架和灯架等多种设备。S-B2R 还拥有参数显示屏，可直观显示模式、电量、色温和亮度等信息，方便用户操作。

数魅 S-B2R RGB 摄影补光灯 拥有强劲的续航能力、多种光效模式和便捷的操作方式，是摄影爱好者和专业人士的理想选择。无论您是进行人像摄影、静物摄影还是视频拍摄，S-B2R 都能助您轻松创作出精彩作品。

产品售价及发售信息

数魅 S-B2R RGB 摄影补光灯的售价为人民币 299 元，将于近期正式发售。

关于数魅

数魅科技是一家专注于影像产品研发和制造的创新型企业，致力于为用户提供高品质、易用的摄影解决方案。数魅的产品线涵盖摄影补光灯、手机支架、麦克风等多种品类，深受广大用户喜爱。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.